vs
Side-by-side financial comparison of KOSS CORP (KOSS) and TScan Therapeutics, Inc. (TCRX). Click either name above to swap in a different company.
KOSS CORP is the larger business by last-quarter revenue ($2.9M vs $2.6M, roughly 1.1× TScan Therapeutics, Inc.). KOSS CORP runs the higher net margin — -19.8% vs -895.1%, a 875.3% gap on every dollar of revenue. On growth, TScan Therapeutics, Inc. posted the faster year-over-year revenue change (286.0% vs -19.6%). KOSS CORP produced more free cash flow last quarter ($-1.1M vs $-32.2M). Over the past eight quarters, KOSS CORP's revenue compounded faster (4.2% CAGR vs -9.7%).
Koss Corporation is a company in Milwaukee, Wisconsin, US that manufactures headphones. The company created the first high-fidelity stereo headphones in 1958.
TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel T cell receptor (TCR) immunotherapies for hard-to-treat cancers. Its proprietary platform identifies high-affinity naturally occurring TCRs targeting tumor antigens, with pipeline candidates spanning hematological malignancies and solid tumors, operating in the global oncology therapeutics market.
KOSS vs TCRX — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.9M | $2.6M |
| Net Profit | $-565.4K | $-23.0M |
| Gross Margin | 29.0% | — |
| Operating Margin | -35.5% | -929.4% |
| Net Margin | -19.8% | -895.1% |
| Revenue YoY | -19.6% | 286.0% |
| Net Profit YoY | -700.6% | 35.8% |
| EPS (diluted) | $-0.06 | $-0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.9M | $2.6M | ||
| Q3 25 | $4.1M | $2.5M | ||
| Q2 25 | $3.1M | $3.1M | ||
| Q1 25 | $2.8M | $2.2M | ||
| Q4 24 | $3.6M | — | ||
| Q3 24 | $3.2M | $1.0M | ||
| Q2 24 | $2.9M | — | ||
| Q1 24 | $2.6M | — |
| Q4 25 | $-565.4K | $-23.0M | ||
| Q3 25 | $243.7K | $-35.7M | ||
| Q2 25 | $-232.7K | $-37.0M | ||
| Q1 25 | $-316.7K | $-34.1M | ||
| Q4 24 | $94.1K | — | ||
| Q3 24 | $-419.5K | $-29.9M | ||
| Q2 24 | $-110.4K | — | ||
| Q1 24 | $-313.8K | — |
| Q4 25 | 29.0% | — | ||
| Q3 25 | 40.0% | — | ||
| Q2 25 | 36.0% | — | ||
| Q1 25 | 39.0% | — | ||
| Q4 24 | 39.5% | — | ||
| Q3 24 | 36.6% | — | ||
| Q2 24 | 40.4% | — | ||
| Q1 24 | 31.9% | — |
| Q4 25 | -35.5% | -929.4% | ||
| Q3 25 | -1.1% | -1475.6% | ||
| Q2 25 | -14.2% | -1256.6% | ||
| Q1 25 | -18.7% | -1669.7% | ||
| Q4 24 | -4.0% | — | ||
| Q3 24 | -19.9% | -3109.8% | ||
| Q2 24 | -11.0% | — | ||
| Q1 24 | -23.1% | — |
| Q4 25 | -19.8% | -895.1% | ||
| Q3 25 | 6.0% | -1422.1% | ||
| Q2 25 | -7.5% | -1201.3% | ||
| Q1 25 | -11.4% | -1571.9% | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | -13.1% | -2849.1% | ||
| Q2 24 | -3.8% | — | ||
| Q1 24 | -11.9% | — |
| Q4 25 | $-0.06 | $-0.18 | ||
| Q3 25 | $0.03 | $-0.28 | ||
| Q2 25 | $-0.02 | $-0.28 | ||
| Q1 25 | $-0.03 | $-0.26 | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $-0.05 | $-0.25 | ||
| Q2 24 | $-0.01 | — | ||
| Q1 24 | $-0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $152.4M |
| Total DebtLower is stronger | — | $32.5M |
| Stockholders' EquityBook value | $30.3M | $123.1M |
| Total Assets | $36.8M | $228.8M |
| Debt / EquityLower = less leverage | — | 0.26× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.5M | $152.4M | ||
| Q3 25 | $16.5M | $184.5M | ||
| Q2 25 | $15.7M | $218.0M | ||
| Q1 25 | $13.0M | $251.7M | ||
| Q4 24 | $9.7M | — | ||
| Q3 24 | $11.9M | $271.1M | ||
| Q2 24 | $14.9M | — | ||
| Q1 24 | $9.9M | — |
| Q4 25 | — | $32.5M | ||
| Q3 25 | — | $32.4M | ||
| Q2 25 | — | $32.3M | ||
| Q1 25 | — | $32.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $30.6M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $30.3M | $123.1M | ||
| Q3 25 | $30.9M | $144.0M | ||
| Q2 25 | $30.6M | $176.7M | ||
| Q1 25 | $30.7M | $210.2M | ||
| Q4 24 | $31.0M | — | ||
| Q3 24 | $30.8M | $229.1M | ||
| Q2 24 | $31.1M | — | ||
| Q1 24 | $31.1M | — |
| Q4 25 | $36.8M | $228.8M | ||
| Q3 25 | $37.7M | $262.2M | ||
| Q2 25 | $37.2M | $298.6M | ||
| Q1 25 | $37.3M | $332.7M | ||
| Q4 24 | $37.4M | — | ||
| Q3 24 | $38.1M | $348.0M | ||
| Q2 24 | $37.2M | — | ||
| Q1 24 | $37.6M | — |
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-760.8K | $-32.0M |
| Free Cash FlowOCF − Capex | $-1.1M | $-32.2M |
| FCF MarginFCF / Revenue | -37.5% | -1253.3% |
| Capex IntensityCapex / Revenue | 10.9% | 6.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-546.7K | $-139.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-760.8K | $-32.0M | ||
| Q3 25 | $762.6K | $-32.5M | ||
| Q2 25 | $-534.9K | $-33.3M | ||
| Q1 25 | $370.4K | $-37.6M | ||
| Q4 24 | $-252.0K | — | ||
| Q3 24 | $201.6K | $-27.9M | ||
| Q2 24 | $-174.0K | — | ||
| Q1 24 | $328.6K | — |
| Q4 25 | $-1.1M | $-32.2M | ||
| Q3 25 | $761.5K | $-33.9M | ||
| Q2 25 | $-541.8K | $-34.5M | ||
| Q1 25 | $306.2K | $-39.1M | ||
| Q4 24 | $-314.3K | — | ||
| Q3 24 | $-155.6K | $-29.3M | ||
| Q2 24 | $-174.8K | — | ||
| Q1 24 | $269.3K | — |
| Q4 25 | -37.5% | -1253.3% | ||
| Q3 25 | 18.7% | -1349.6% | ||
| Q2 25 | -17.6% | -1123.1% | ||
| Q1 25 | 11.0% | -1801.8% | ||
| Q4 24 | -8.8% | — | ||
| Q3 24 | -4.9% | -2792.0% | ||
| Q2 24 | -6.0% | — | ||
| Q1 24 | 10.2% | — |
| Q4 25 | 10.9% | 6.7% | ||
| Q3 25 | 0.0% | 56.8% | ||
| Q2 25 | 0.2% | 41.6% | ||
| Q1 25 | 2.3% | 70.6% | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 11.2% | 130.6% | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 2.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | 3.13× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -2.68× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
